EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Apparent Treatment-Resistant Hypertension in the First Year Associated With Cardiovascular Mortality in Peritoneal Dialysis Patients

Qingyao Zhu, Zhihao Huo, Fang Zeng, Nirong Gong, Peiyi Ye, Jianyi Pan, Yaozhong Kong, Xianrui Dou, Di Wang, Shuting Huang, Cong Yang, Dehui Liu und 2 weitere

American Journal of Hypertension · 2024

DOI: 10.1093/ajh/hpae010 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift American Journal of Hypertension, 2024. Verfasst von Qingyao Zhu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Peritoneal Dialysis, Hypertension, Cardiovascular Diseases. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Nature and Science Foundation of China, Outstanding Youths Development Scheme of Nanfang Hospital, Southern Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Few reports have focused on the association between apparent treatment-resistant hypertension (aTRH) and cardiovascular (CV) mortality in peritoneal dialysis (PD) population, thus we conducted this retrospective cohort to explore it. METHODS This was a retrospective cohort study conducted from January 2011 to January 2020 with PD patients in 4 Chinese dialysis centers. aTRH was defined according to the American College of Cardiology and American Heart Association guidelines. aTRH duration was calculated as the total number of months when patients met the diagnostic criteria in the first PD year. The primary outcome was CV mortality, and the secondary outcomes were CV events, all-cause mortality, combined endpoint (all-cause mortality and transferred to hemodialysis [HD]), and PD withdrawal (all-cause mortality, transferred to HD, and kidney transplantation). Cox proportional hazards models were used to assess the association. RESULTS A total of 1,422 patients were finally included in the analysis. During a median follow-up period of 26 months, 83 (5.8%) PD patients incurred CV mortality. The prevalence of aTRH was 24.1%, 19.9%, and 24.6% at 0, 3, and 12 months after PD initiation, respectively. Overall, aTRH duration in the first PD year positively associated with CV mortality (per 3 months increment, adjusted hazards ratio [HR], 1.29; 95% confidence interval 1.10, 1.53; P = 0.002). After categorized, those with aTRH duration more than 6 months presented the highest adjusted HR of 2.92. Similar results were found for secondary outcomes, except for the CV event. CONCLUSIONS Longer aTRH duration in the first PD year is associated with higher CV mortality and worse long-term clinical outcomes. Larger studies are warranted to confirm these findings. CLINICAL TRIALS REGISTRATION There is no clinical trial registration for this retrospective study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peritoneal DialysisHypertensionCardiovascular DiseasesHumansMaleFemaleMiddle AgedRetrospective StudiesAgedTime FactorsAdultChinaAntihypertensive AgentsRisk AssessmentDrug ResistanceKidney Failure, ChronicBlood PressureRisk FactorsTreatment OutcomePrevalenceCause of Death

Stichwörter der Autor:innen

aTRH durationall-cause mortalityapparent treatment-resistant hypertensionblood pressurecardiovascular mortalityhypertensionperitoneal dialysis

Substanzen

Antihypertensive Agents

Autor:innen und Institutionen

  • Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • National Clinical Research Center for Kidney Disease, Guangzhou, China.
  • State Key Laboratory of Organ Failure Research, Guangzhou, China.
  • Guangdong Provincial Institute of Nephrology, Guangzhou, China.
  • Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou, China.
  • School of Nursing, Southern Medical University, Guangzhou, China.

ORCID-Profile: Jun Ai

Förderung

  • Nature and Science Foundation of China
  • Outstanding Youths Development Scheme of Nanfang Hospital, Southern Medical University

Zitieren

APA

Zhu, Q., Huo, Z., Zeng, F., Gong, N., Ye, P., Pan, J., Kong, Y., Dou, X., Wang, D., Huang, S., Yang, C., Liu, D., Zhang, G., & Ai, J. (2024). Apparent Treatment-Resistant Hypertension in the First Year Associated With Cardiovascular Mortality in Peritoneal Dialysis Patients. American Journal of Hypertension. https://doi.org/10.1093/ajh/hpae010

Vancouver

Zhu Q, Huo Z, Zeng F, Gong N, Ye P, Pan J, et al. Apparent Treatment-Resistant Hypertension in the First Year Associated With Cardiovascular Mortality in Peritoneal Dialysis Patients. American Journal of Hypertension. 2024. doi:10.1093/ajh/hpae010

BibTeX
@article{Zhu2024,
  author = {Zhu, Qingyao and Huo, Zhihao and Zeng, Fang and Gong, Nirong and Ye, Peiyi and Pan, Jianyi and Kong, Yaozhong and Dou, Xianrui and Wang, Di and Huang, Shuting and Yang, Cong and Liu, Dehui and Zhang, Guangqing and Ai, Jun},
  title = {Apparent Treatment-Resistant Hypertension in the First Year Associated With Cardiovascular Mortality in Peritoneal Dialysis Patients},
  journal = {American Journal of Hypertension},
  year = {2024},
  doi = {10.1093/ajh/hpae010}
}
Kostenlos starten →